Amstelveen, North Holland, Netherlands
I am an experienced (25+ years) pharmaceutical, drug delivery, medical device and digital health executive with entrepreneurial, small and large company and strategic consulting background. I am innovative (more than a dozen patents to my name), published in peer reviewed journals and well connected. Striving to make a difference I co-founded a successful drug delivery company, growing it into a specialty pharma and selling it to one of the Top Ten in the industry. My extensive practical knowledge encompasses strategic planning, business development, sales, marketing, brand development, fund raising, alliance management, account management and Director’s positions. Highly personable and energetically funny (think Robin Williams talking science and technology) I can lighten the mood in any room while motivating and building team consensus to achieve stretch goals or to develop and kick-off new strategic initiatives. I grew up believing in the life sciences industry. My father was a physician and medical researcher, so I believed medicine was magic. I still believe it today. But now I also know that drugs are only effective when chosen appropriately and taken as prescribed. Our digital world can bring this home. We now have the tools to track what is missed and when, and to create the habits to improve adherence and outcomes. This is the revolution that can cost-effectively improve the health and well-being of all. Strengths: • Innovative & Strategic • Impactful and entertaining presenter • Customer focused and in tune with market developments • Able to distill market strategy to product practice • Enthusiastic team builder • Superlative selling skills Specialties: • Respiratory market, treatments and delivery systems • Digital Health and Smart Technology • eConnected drug delivery solutions • Adherence and Compliance Improvement techniques • Product profile development • User Experience and Product Design • Product innovation • Brand development
PulmoBoMEd's lead product PBM-Hale™: is an innovative, non-invasive sampler of the deep lung. It collects uncontaminated aerosolized fluids, gasses, and volatile organic compounds (VOCs)—exclusively from the small airways in the distal lung—giving access to all molecular markers in the airway lining fluid. PBM-Hale™ will be of interest to assay manufactuers, researchers, CROs and pharma companies seeking to identify and stratify patients with a range of lung conditions, to confirm diagnosis, improve clinical trial outcomes and ensure the optimal treatment.
Gilbert is developing the next generation of soft mist inhalers based on proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for lung patients. Gilbert’s breath actuated, smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drug to the desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle and efficient, breath-actuated delivery of both small and large molecule therapies in both solution and suspension formulations. Visit us at www.gilbert.eu or contact us at [email protected] to learn if electrospray is suitable for your application.
HCmed Innovations provides a comprehensive drug-device combination platform built on its core product portfolio of vibrating mesh nebulizers. Our mission is to create highly integrated drug-device combination products for affordable-best-quality, featuring nebulization of high value therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. In order to achieve optimal aerosol performance for diverse formulations, we closely work with our partners to tailor the components and parameters of our mesh technology. By combining the strength of Taiwan's world-class manufacturing industry and a well-established GMP certified manufacturing facility, our products have received approval by multiple health authorities and have been launched in selected regions.
PharmConnect provides executive level advisory, consultancy and contract services in the pharmaceutical, MedTech and drug delivery industries, with specialty in respiratory, digital health, commercial strategy, business development, partnering, sales & marketing, M&A and Directorships.